Skip to content

Comparing treatments for fluid in the lungs: which is most effective?

CAPE-CHOICE: Comparative Results of Vasodilatory Strategies in Acute Pulmonary Edema - CAPE-CHOICE Comparative Results of Vasodilatory Strategies in Acute Pulmonary Edema

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3t7by45
Enrollment
Unknown
Registered
2025-12-08
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nitroglycerin

Interventions

Randomized controlled trial comparing two vasodilatory strategies in the treatment of acute pulmonary edema, including a total of 150 participants. Participants will be randomized through opaque seale
s clinical response. The study is open-label, meaning that both researchers and participants will know which medication is being administered, as knowledge of the medication is necessary for appropria

Sponsors

Santa Casa de Misericórdia da Bahia
Lead Sponsor
Santa Casa de Misericórdia da Bahia
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with diagnosis of acute pulmonary edema in the emergency unit requiring vasodilator; age 18 years or older; both genders

Exclusion criteria

Exclusion criteria: Patients under 18 years of age; patients with cardiogenic shock; patients with acute coronary syndrome; patients with contraindication to any of the drugs; pregnant patients

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of nitroglycerin versus sodium nitroprusside in the management of acute pulmonary edema in adults, verified by comparative analysis of all clinical parameters between T0 and T6h, using measurements of respiratory rate, use of accessory muscles, oxygen saturation, systolic and diastolic blood pressure, ventilatory support, ventilatory pattern and pulmonary ultrasound (POCUS), observing statistically significant difference between groups in the improvement of clinical and radiological parameters

Secondary

MeasureTime frame
To assess the time to resolution of respiratory symptoms between the two treatment groups, verified by comparative analysis of progressive clinical evolution during the 6-hour protocol, using respiratory rate, oxygen saturation, use of accessory muscles and changes in ventilatory support, observing statistically significant difference in resolution time between nitroglycerin and sodium nitroprusside; to compare the incidence of serious adverse events (hypotension and arrhythmias) related to drug use, verified by continuous recording during the 6-hour protocol, using measurements of systolic and diastolic blood pressure at T0, T1h, T2h and T6h and monitoring of cardiac rhythm disturbances, observing statistically significant difference in the frequency and severity of hypotension and arrhythmias between groups

Countries

Brazil

Contacts

Public ContactAna Beatriz Carvalho

Santa Casa de Misericórdia da Bahia

andrade.64@hotmail.com+55(71)992048551

Outcome results

None listed

Source: REBEC (via WHO ICTRP)